NETWORK META-ANALYSIS: COMPARATIVE EFFICACY OF BIOLOGICS IN THE TREATMENT OF BIOLOGIC-NAiVE JAPANESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

被引：0
|
作者：
Hibi, Toshihumi
Kamae, Isao
Pinton, Philippe
Ursos, Lyann
Iwakiri, Ryuichi
Hather, Greg
Patel, Haridarshan
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2019年 / 25卷
关键词：
D O I：
10.1093/ibd/izy393.043
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P038
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [31] Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
    Chu, Xinqiao
    Biao, Yaning
    Liu, Chengjiang
    Zhang, Yixin
    Liu, Chenxu
    Ma, Ji-Zheng
    Guo, Yufeng
    Gu, Yaru
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [32] Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis
    Shehab, Mohammad
    Alrashed, Fatema
    Alsayegh, Abdulwahab
    Aldallal, Usama
    Ma, Christopher
    Narula, Neeraj
    Jairath, Vipul
    Singh, Siddharth
    Bessissow, Talat
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (02) : 250 - 262
  • [33] Cost Per Clinical Outcomes With Biologics for the Treatment of Moderately to Severely Active Ulcerative Colitis
    Jansen, Jeroen P.
    Mody, Reema
    Patel, Haridarshan
    Lorenzi, Maria
    Ursan, Iulia
    Alberton, Mark
    GASTROENTEROLOGY, 2015, 148 (04) : S1 - S2
  • [34] Cost per clinical outcomes with biologics for the treatment of moderately to severely active ulcerative colitis
    Jansen, J.
    Mody, R.
    Ursan, I.
    Lorenzi, M.
    Patel, H.
    Alberton, M.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S239 - S240
  • [35] Network Meta-Analysis of Targeted Immunomodulators in the Treatment of Biologic-NaiVe Psoriatic Arthritis
    Strand, Vibeke
    Husni, M. Elaine
    Singh, Rakesh
    Betts, Keith
    Song, Yan
    Griffith, Jenny
    Ganguli, Arijit
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [36] Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis
    Panaccione, Remo
    Collins, Eric B.
    Melmed, Gil Y.
    Vermeire, Severine
    Danese, Silvio
    Higgins, Peter D. R.
    Kwon, Christina S.
    Zhou, Wen
    Ilo, Dapo
    Sharma, Dolly
    Gonzalez, Yuri Sanchez
    Wang, Si-Tien
    CROHNS & COLITIS 360, 2023, 5 (02)
  • [37] Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
    Kobayashi, Taku
    Ito, Hiroaki
    Ashida, Toshifumi
    Yokoyama, Tadashi
    Nagahori, Masakazu
    Inaba, Tomoki
    Shikamura, Mitsuhiro
    Yamaguchi, Takayoshi
    Hori, Tetsuharu
    Pinton, Philippe
    Watanabe, Mamoru
    Hibi, Toshifumi
    INTESTINAL RESEARCH, 2021, 19 (04) : 448 - +
  • [38] Long-term efficacy and safety of thiopurine in biologic-naive Japanese patients with ulcerative colitis: a multicentre retrospective study
    Takagi, T.
    Matsuura, M.
    Yamada, S.
    Bamba, S.
    Hotta, Y.
    Uchiyama, K.
    Naito, Y.
    Nakase, H.
    Andoh, A.
    Kawamura, T.
    Katsushima, S.
    Kusaka, T.
    Obata, H.
    Kogawa, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S337 - S338
  • [39] Biological agents for moderately-to-severely active ulcerative colitis in adults: a network meta-analysis of randomized controlled trials
    Danese, S.
    Fiorino, G.
    Peyrin-Biroulet, L.
    Lucenteforte, E.
    Virgili, G.
    Moja, L.
    Bonovas, S.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S296 - S296
  • [40] Comparative Efficacy and Safety of Ozanimod vs Adalimumab and Vedolizumab in Patients with Moderately to Severely Active Ulcerative Colitis
    Dubinsky, Marla C.
    Betts, Keith A.
    LaPensee, Kenneth
    Eren, Devrim
    Kim-Romo, Dawn
    Yin, Lei
    Tang, Wenxi
    Gupte-Singh, Komal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S314 - S314
12345